|
|
| gastrin-17 |
|
| CHEBI:75441 |
|
| One of the primary forms of gastrin that is a 17-membered peptide consisting of Glp, Gly, Pro, Trp, Leu, Glu, Glu, Glu, Glu, Glu, Ala, Tyr, Gly, Trp, Met, Asp and Phe-NH2 residues joined in sequence. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
|
|
Molfile
XML
SDF
|
|
|
|
|
InChI=1S/C97H124N20O31S/c1- 49(2)39-68(114-95(146)71(43-54-46-100-59-18-11-9-16-57(54)59)116-97(148)73-19-12-37-117(73)76(121)48-102-85(136)60-24-30-74(119)104-60)93(144)110-65(29-35-81(130)131)91(142)109-64(28-34-80(128)129)90(141)108-63(27-33-79(126)127)89(140)107-62(26-32-78(124)125)88(139)106-61(25-31-77(122)123)87(138)103-50(3)84(135)113-69(41-52-20-22-55(118)23-21-52)86(137)101-47-75(120)105-70(42-53-45-99-58-17-10-8-15-56(53)58)94(145)111-66(36-38-149-4)92(143)115-72(44-82(132)133)96(147)112-67(83(98)134)40-51-13-6-5-7-14-51/h5-11,13-18,20-23,45-46,49-50,60-73,99-100,118H,12,19,24-44,47-48H2,1-4H3,(H2,98,134)(H,101,137)(H,102,136)(H,103,138)(H,104,119)(H,105,120)(H,106,139)(H,107,140)(H,108,141)(H,109,142)(H,110,144)(H,111,145)(H,112,147)(H,113,135)(H,114,146)(H,115,143)(H,116,148)(H,122,123)(H,124,125)(H,126,127)(H,128,129)(H,130,131)(H,132,133)/t50-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-/m0/s1 |
| GKDWRERMBNGKCZ-RNXBIMIWSA-N |
| CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |
|
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
|
cholecystokinin antagonist
A hormone antagonist that inhibits the action of the peptide hormone cholecystokinin.
(via gastrin )
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via gastrin )
hormone
Originally referring to an endogenous compound that is formed in specialized organ or group of cells and carried to another organ or group of cells, in the same organism, upon which it has a specific regulatory function, the term is now commonly used to include non-endogenous, semi-synthetic and fully synthetic analogues of such compounds.
(via peptide hormone )
|
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
cholecystokinin antagonist
A hormone antagonist that inhibits the action of the peptide hormone cholecystokinin.
(via gastrin )
|
|
View more via ChEBI Ontology
|
5-oxo-L-prolylglycyl-L-prolyl-L-tryptophyl-L-leucyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-alanyl-L-tyrosylglycyl-L-tryptophyl-L-methionyl-L-α-aspartyl-L-phenylalaninamide
|
|
G 17
|
ChemIDplus
|
|
Gastrin heptadecapeptide
|
ChemIDplus
|
|
Glp-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2
|
ChEBI
|
|
Heptadecapeptide gastrin
|
KEGG COMPOUND
|
|
Little gastrin
|
KEGG COMPOUND
|
|
Little gastrin I
|
ChemIDplus
|
|
11842134
|
Reaxys Registry Number
|
Reaxys
|
|
60748-06-3
|
CAS Registry Number
|
ChemIDplus
|
|
8188172
|
Reaxys Registry Number
|
Reaxys
|
|
21030667
|
PubMed citation
|
Europe PMC
|
|
21175799
|
PubMed citation
|
Europe PMC
|
|
21389862
|
PubMed citation
|
Europe PMC
|
|
22037174
|
PubMed citation
|
Europe PMC
|
|
22138052
|
PubMed citation
|
Europe PMC
|
|
22696910
|
PubMed citation
|
Europe PMC
|
|
22784345
|
PubMed citation
|
Europe PMC
|
|
23117263
|
PubMed citation
|
Europe PMC
|
|
23311704
|
PubMed citation
|
Europe PMC
|
|
23349211
|
PubMed citation
|
Europe PMC
|
|
23658576
|
PubMed citation
|
Europe PMC
|
|
23886209
|
PubMed citation
|
Europe PMC
|
|
23930120
|
PubMed citation
|
Europe PMC
|
|
